medigraphic.com

2014, Number 3

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2014; 52 (3)

The role and importance of the microRNAs in the diagnosis and development of diseases

Rico-Rosillo MG, Vega-Robledo GB, Oliva-Rico D

Language: Spanish
References: 35
Page: 302-307
PDF size: 183.63 Kb.


ABSTRACT

MicroRNAs are small non-coding ribonucleic acids of endogenous nature. They persist in various groups of eukaryotes and perform critical functions during the development and the cell homeostasis. They have from 19 to 25 nucleotides in length and regulate the translation of the target RNA messenger (mRNA). MicroRNAs can inhibit its translation, stabilizing it or inducing its degradation. They regulate the genetic expression and are involved in the control of cellular functions (the differentiation, the proliferation, the apoptosis and the metabolism). They are also involved in the response to stress, the angiogenesis, the oncogenesis and in cardiovascular functions. That is the reason why their abnormal expressions are associated to many pathological conditions. The aim of this review was to describe the importance of microRNAs, their biological origin and their role in various diseases, such as cancer, diabetes, obesity, and neurological disorders. The microRNAs are an attractive therapeutic target because it has been observed that just one of them can regulate several genes and it could influence all the signaling route; besides, they could inhibit themselves in vivo without adverse effects related to the usual therapeutic agents. Since they can be detected in serum, plasma, urine and saliva samples in a stable, reproducible and consistent form between individuals of the same species, we expect them to be useful as biomarkers for the clinical diagnosis and the monitoring of diseases.


REFERENCES

  1. Bernardo BC, Charchar FJ, Lin RC, McMullen JR. A microRNA guide for clinicians and basic scientists: Background and experimental techniques. Heart Lung Circ. 2012;21(3):131-42.

  2. Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350-5.

  3. Zen K, Zhang CY. Circulating microRNAs: A novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev. 2012;32(2):326-48.

  4. Xu J, Zhao J, Evan G, Xiao C, Cheng Y, Xiao J. Circulating microRNAs: Novel biomarkers for cardiovascular diseases. J Mol Med (Berl). 2012;90(8): 865-75.

  5. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell. 2009;136(2):215-33. Disponible en http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794896/

  6. Borchert GM, Lanier W, Davidson BL. RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol. 2006;13(12):1097-101.

  7. Latronico MV, Catalucci D, Condorelli G. Emerging role of microRNAs in cardiovascular biology. Circ Res. 2007;101(12):1225-36.

  8. van Rooij E, Marshall WS, Olson EN. Toward microRNA- based therapeutics for heart disease: The sense in antisense. Circ Res. 2008;103(9):919-28. Disponible en http://www.ncbi.nlm.nih.gov/pmc/ articles/pmid/18948630/

  9. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, et al. Circulating microRNA: A novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 2010;31(6):659-66.

  10. Chang TC, Mendell JT. MicroRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet. 2007;8:215-39.

  11. 11 Barroso-del Jesús A, Lucena-Aguilar G, Menéndez P. The miR-302-367 cluster as a potential stemness regulator in ESCs. Cell Cycle. 2009;8(3):394-8.

  12. Cortez MA, Bueso-Ramos C, Ferdin J, López-Berestein G, Sood KA, Kalin AG. MicroRNAs in body fl uidsthe mix of hormones and biomarkers. Nat Rev Clin Oncol. 2011;8(8):467-77. Disponible en http://www. ncbi.nlm.nih.gov/pmc/articles/pmid/21647195/

  13. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105(30): 10513-8. Disponible en http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC2492472/

  14. Zheng D, Haddadin S, Wang Y, Gu LQ, Perry MC, Freter CE, et al. Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol. 2011;4(6):575-86. Disponible en http:// www.ncbi.nlm.nih.gov/pmc/articles/pmid/21904633/

  15. Ma L, Teruya-Feldstein J, Weinberg RA. Tumor invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007;449:682-8.

  16. Schonrock N, Ke YD, Humphreys D, Staufenbiel M, Ittner LM, Preiss T, et al. Neuronal microRNA deregulation in response to Alzheimer’s disease amyloid-be ta. PLoS One. 2010;5(6):11070. Disponible en http:// www.ncbi.nlm.nih.gov/pmc/articles/PMC288 4018/

  17. Geekiyanage H, Jicha GA, Nelson PT, Chan C. Blood serum miRNA: Non-invasive biomarkers for Alzheimer’s disease. Expl Neurol. 2012;235(2):491- 6. Disponible en http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3361462/

  18. Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R. Diabetes mellitus, a microRNA-related disease? Transl Res. 2011;157(4):253-64.

  19. Kolfschoten IG, Roggli E, Nesca V, Regazzi R. Role and therapeutic potential of microRNAs in diabetes. Diabetes Obes Metab. 2009;11(Suppl 4):118-29.

  20. Kong L, Zhu J, Han W, Jiang X, Xu M, Zhao Y, et al. Signifi cance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: A clinical study. Acta Diabetol. 2011;48(1):61-9.

  21. Lovis P, Roggli E, Laybutt DR, Gattesco S, Yang JY, Widmann C, et al. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta- cell dysfunction. Diabetes. 2008;57(10):2728-36.

  22. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006;38(2):228-33.

  23. Xiao J, Luo X, Lin H, Zhang Y, Lu Y, Wang N, et al. MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem. 2007;282(32):28656. Disponible en http://www.ncbi.nlm.nih.gov/pmc/articles/pmid/ 21961173/

  24. Saucedo R, Zárate A, Basurto L, Hernández M, Puello E, Galván R, et al. Relationship between circulating adipokines and insulin resistance during pregnancy and postpartum in women with gestational diabetes. Arch Med Res. 2011;42(4):318-23.

  25. Zhao Ch, Dong J, Jiang T, Shi Z, Yu B, Zhu Y, et al. Early second-trimester serum miRNA profi ling predicts gestational diabetes mellitus. PLoS One. 2011; 6(8):e23925.

  26. Krapivner S, Chernogubova E, Ericsson M, Ahlbeck- Glader C, Hamsten A, van ‘t Hooft FM. Human evidence for the involvement of insulin-induced gene 1 in the regulation of plasma glucose concentration. Diabetologia. 2007;50(1):94-102.

  27. Du B, Ma LM, Huang MB, Zhou H, Huang HL, Shao P, et al. High glucose down-regulates miR-29-a to increase collagen IV production in HK-2 cells. FEBS Lett. 2010;584(4):811-6.

  28. Nakanishi N, Nakagawa Y, Tokushige N, Aoki N, Matsuzaka T, Ishii K, et al. The up-regulation of microRNA- 335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice. Biochem Biophys Res Commun. 2009;385(4): 492-6.

  29. Parra P, Serra F, Palou A. Expression of adipose microRNAs is sensitive to dietary conjugated linoleic acid treatment in mice. PLoS One. 2010;5(9):e13005. Disponible en http://www.ncbi.nlm.nih.gov/pmc/articles /PMC2946340/

  30. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18(10):997-1006. Disponible en http://www.nature.com/cr/journal/v18/ n10/full/cr2008282a.html

  31. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, et al. Plasma microRNA profi ling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010;107(6):810-7. Disponible en http://circres.ahajournals.org/content/ 107/6/810.long

  32. Seto AG. The road toward microRNA therapeutics. Int J Biochem Cell Biol. 2010;42(8):1298-305.

  33. Montgomery RL, van Rooij E. Therapeutics advances in microRNA targeting. J Cardiovasc Pharmacol. 2011;57(1):1-7.

  34. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: A diagnostic marker for lung cancer. Clin Lung Cancer. 2009;10 (1):42-6.

  35. Wang K, Zhang S, Weber J, Baxter D, Galas DJ. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 2010; 38(20):7248-59. Disponible en http://www.ncbi.nlm. nih.gov/pmc/articles/PMC2978372/




2020     |     www.medigraphic.com